Italy at a glance
- Population
- 58.9 million 2025
- Life expectancy at birth
- 84.0 years, 2024
- People aged 65 and over
- 25.1 % of people, 2025
- Health spending per person
- 3,398 US$ per person, 2024
- Doctors
- 4.19 per 1,000 people, 2022
Italy E-Pharmacy Market Industry Trends and Forecast to 2034: Segmented by (Product, Platform, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Italy · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Germany at $4.76 Bn.
Russia at 15.1% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$5.79 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $2.23 Bn | — | — |
| 2025 (base) | $2.54 Bn | +$314.2 Mn | — |
| 2026 (forecast) | $2.90 Bn | +$358.4 Mn | +14.1% |
| 2027 (forecast) | $3.31 Bn | +$409.0 Mn | +30.2% |
| 2028 (forecast) | $3.78 Bn | +$466.7 Mn | +48.5% |
| 2029 (forecast) | $4.31 Bn | +$532.5 Mn | +69.5% |
| 2030 (forecast) | $4.92 Bn | +$607.5 Mn | +93.4% |
| 2031 (forecast) | $5.61 Bn | +$693.2 Mn | +120.7% |
| 2032 (forecast) | $6.40 Bn | +$790.9 Mn | +151.8% |
| 2033 (forecast) | $7.30 Bn | +$902.5 Mn | +187.3% |
| 2034 (forecast) | $8.33 Bn | +$1.03 Bn | +227.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US
$44.23 Bn
China
$11.31 Bn
Canada
$9.70 Bn
Japan
$8.24 Bn
Germany
$4.76 Bn
UK
$3.36 Bn
Brazil
$3.26 Bn
France
$2.87 Bn
Spain
$2.64 Bn
Italy (this report)
$2.54 Bn
India
$2.49 Bn
Ecuador
$2.21 Bn
Saudi Arabia
$2.09 Bn
Mexico
$1.96 Bn
Australia
$1.71 Bn
Russia
$1.15 Bn
New Zealand
$1.12 Bn
South Africa
$746.5 Mn
UAE
$696.6 Mn
Egypt
$351.1 Mn
Philippines
$295.3 Mn
Malaysia
$203.3 Mn
Hong Kong
$202.1 Mn
Thailand
$171.3 Mn
Singapore
$158.4 Mn
Kenya
$96.1 Mn
| Market size, 2025 | $2.54 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $8.33 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 14.1% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product and platform (see all) |
| Key players | Amazon Pharmacy, CVS Health, Walgreens, Tata 1mg, PharmEasy and 1 more (see all) |
| Regulator in Italy | EU MDR and Ministry of HealthSource: European Commission, medical devices. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
E-pharmacies sell medicines and health products online and deliver them to the home.
Key segments of the e-Pharmacy market include product (Prescription Medicines, OTC Products and Personal Care) and platform (App-Based and Web-Based).
Rising incomes, fast-growing private hospital chains, medical tourism, government health reforms and a young, digital-first population are driving the e-Pharmacy market.
Public-private partnerships, digital health and growing middle classes in Asia, the Middle East, Africa and Latin America give the e-Pharmacy market strong room to grow.
Uneven quality standards, limited insurance coverage, high out-of-pocket costs and regulatory differences between countries hold back the e-Pharmacy market.
The e-Pharmacy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Under the EU Medical Device Regulation (MDR), software used for diagnosis or treatment counts as a medical device; the Ministry of Health oversees it in Italy.[1] The National Health Service (SSN), run by the regions, gives universal cover, and AIFA decides which medicines it pays for.[2]
[1] European Commission, medical devices. Checked 14 Nov 2026.
[2] Italian Ministry of Health. Checked 14 Nov 2026.
Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the e-Pharmacy market. Government digital health programs in Italy are speeding up adoption.
What doctors and scientists are doing in E-Pharmacy right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
From our blog
Italy
Italy
Italy
Italy
Italy
Italy
Pharmaceuticals · Italy
Pharmaceuticals · Italy
Medical Devices · Italy
Healthcare Services · Italy
Pharmaceuticals · Italy
Healthcare Services · Italy